Skip to main content
Caplight Logo









axplora

axplora

Private

Last Round

M&A

Apr 7, 2022

Total Funding Raised

$43.56M

Company Overview

A contract development and manufacturing organization (CDMO) and producer of active pharmaceutical ingredients (APIs) and advanced intermediates for the pharmaceutical industry.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Book a demo to explore historical pricing and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Book a demo

For institutional investors. Book with your work email.

axplora Comparables

Compare axplora with similar companies based on industry and business-model similarity.

No public comparables are available for axplora. Request access to learn about comparables coverage.

Book a demo

For institutional investors. Book with your work email.

axplora Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AApr 7, 2022
Buyout/LBOFeb 14, 2020
DebtFeb 19, 2019
RecapMar 16, 2012
Buyout/LBONov 29, 2006
Book a demo to see all 5 rounds

For institutional investors. Book with your work email.

axplora Filings

Explore SEC and related filing metadata, where available.

axplora filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

Headquarters—
Year Founded1946
Last FundingApr 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?